Startups & growth Analysis
Immunartes takes two approaches to preventing hard-to-fight staph infections
Immunartes is developing a vaccine and an antibody for different prevention needs, with both programs still in preclinical research.
I
MoneyMakers coverage
Immunartes: news & coverage
Page 1 of 1 · 1 report
Immunartes develops preclinical vaccine and antibody candidates intended to prevent Staphylococcus aureus infections.
Published reporting on Immunartes. Entries describe developments as reported on their publication dates.
All reporting
